Journal Club: A Review of Topical and Intralesional Therapeutics for Different Types of Alopecia

    Egídio Freitas, Miguel Nogueira, Ángel Manuel Rosell‐Díaz … Sophia Mohme
    Studysummary This study found that using a method based on absolute PASI, patients with psoriasis receiving brodalumab had a higher probability of achieving and maintaining a treatment response over 52 weeks compared to those receiving ustekinumab.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on stm.cairn.info →
    Discuss this study in the Community →